4th Quarter - Report
LINCOLN POLICY GROUP for PFIZER
Firm
Client
Income
$80,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. COVID relief proposals Outreach on biosimilar shared savings.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAN ELLING | — |
| ROBERT HOLIFIELD | — |
| HANNAH LAMBIOTTE SMITH | — |
| BLANCHE LINCOLN | — |
| COLIN ROSKEY | — |
| THOMAS A SCULLY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.